RedHill Biopharma (RDHL) Notes Payables (2022)
RedHill Biopharma (RDHL) reported Notes Payables of $115.2 million for Q4 2022.
RedHill Biopharma (RDHL) Notes Payables (2022) Analysis & Trends
RedHill Biopharma (RDHL) has 1 years of Notes Payables data on file, last reported at $115.2 million in Q4 2022.
- Notes Payables for Q4 2022 came in at $115.2 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $115.2 million (changed N/A YoY), and the FY2022 annual result was $115.2 million, changed N/A from the prior year.
- Notes Payables held at $115.2 million in Q4 2022 per RDHL's latest filing.
- Over five years, Notes Payables peaked at $115.2 million in Q4 2022 and troughed at $115.2 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | RedHill Biopharma | 142.34 Mn | 142.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 115.22 Mn |